Abstract

Background: Prostate Cancer (PCa) is the most common malignant tumor in males and Biochemical Relapse (BCR) consists of a challenging scenario compared to primary staging due to small volume of disease and low PSA levels. Prostate-Specific Membrane Antigen (PSMA), Positron Emission Tomography (PET) presents superior performance and strongly affects therapeutic choice.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call